Topical and systemic retinoid therapy for cutaneous T-cell lymphoma-Reference-Cited by-同舟云学术

Topical and systemic retinoid therapy for cutaneous T-cell lymphoma

Published:2003-12 Issue:6 Volume:17 Page:1405-1419
ISSN:0889-8588
Container-title:Hematology/Oncology Clinics of North America
language:en
Short-container-title:Hematology/Oncology Clinics of North America

Author:

Kempf Werner,Kettelhack Natascha,Duvic Madeleine,Burg Günter

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference85 articles.

1. Cutaneous lymphomas, pseudolymphomas, and related disorders;Burg,1983

2. Cutaneous lymphomas;Burg;Curr Probl Dermatol,1997

3. Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality;Weinstock;Am J Public Health,1999

4. From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors [comment];Burg;Arch Dermatol,2001

5. Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates;Dummer;J Cutan Pathol,1995

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2022-10-20

2. Current treatment strategies and emerging therapies for cutaneous lymphoma;The Journal of Dermatology;2021-12-27

3. Cutaneous T‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2021-08-02

4. Untangling the Cooperative Role of Nuclear Receptors in Cardiovascular Physiology and Disease;International Journal of Molecular Sciences;2021-07-21

5. Outlines of the Japanese guidelines for the management of primary cutaneous lymphomas 2020;The Journal of Dermatology;2020-11-27